Todralazine hepatotoxicity: A sting in the histone tail

Journal of Hepatology

Volumn 46, Issue 2, 2007, Pages 189-192

  Elsharkawy, Ahmed M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLINE; DILTIAZEM; HISTONE; HISTONE H4; HYDRALAZINE; ISONIAZID; TODRALAZINE;

ACETYLATION; CELL PROLIFERATION; CELL REGENERATION; CHROMATIN IMMUNOPRECIPITATION; DEACETYLATION; EDITORIAL; GENOTYPE; HEPATITIS; HEPATITIS A; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACETYLATION; ANIMALS; ANTIHYPERTENSIVE AGENTS; HISTONES; HUMANS; LIVER; LIVER FAILURE; MICE; TODRALAZINE;

EID: 33845619459     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.11.007     Document Type: Editorial

References (17)

1. Saha A., Wittmeyer J., and Cairns B.R. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7 (2006) 437-447
2. Wegel E., and Shaw P. Gene activation and deactivation related changes in the three-dimensional structure of chromatin. Chromosoma 114 (2005) 331-337
3. Jin J., Cai Y., Li B., Conaway R.C., Workman J.L., Conaway J.W., et al. In and out: histone variant exchange in chromatin. Trends Biochem Sci 30 (2005) 680-687
4. Murray K. The acid extraction of histones from calf thymus deoxyribonucleoprotein. J Mol Biol 15 (1966) 409-419
5. Clayton A.L., Hazzalin C.A., and Mahadevan L.C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23 (2006) 289-296
6. Mersfelder E.L., and Parthun M.R. The tale beyond the tail: histone core domain modifications and the regulation of chromatin structure. Nucleic Acids Res 34 (2006) 2653-2662
7. Turner B.M. Reading signals on the nucleosome with a new nomenclature for modified histones. Nat Struct Mol Biol 12 (2005) 110-112
8. Fraga M.F., and Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle 4 (2005) 1377-1381
9. Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435 (2005) 1262-1266
10. Latasa M.U., Boukaba A., Garcia-Trevijano E.R., Torres L., Rodriguez J.L., Caballeria J., et al. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration. FASEB J 15 (2001) 1248-1250
11. Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ 2006.
12. Murata K., Hamada M., Sugimoto K., and Nakano T. A novel mechanism for drug-induced liver failure: Inhibition of histone acetylation by hydralazine derivatives. J Hepatol 46 (2007) 322-329
13. Tameda Y., Hamada M., Takase K., Nakano T., and Kosaka Y. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative). Hepatology 23 (1996) 465-470
14. Fausto N., Campbell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) S45-S53
15. Pugh B.F. HATs off to PIC assembly. Mol Cell 23 (2006) 776-777
16. Dion M.F., Altschuler S.J., Wu L.F., and Rando O.J. Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci USA 102 (2005) 5501-5506
17. Kurdistani S.K., Tavazoie S., and Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 117 (2004) 721-733